openPR Logo
Press release

Cephalosporin Market Growing $1,99,754 million by 2023

11-23-2017 01:22 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Research Beam Market

Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. It resembles penicillin and hence is used as an alternative for patients who are allergic to penicillin. It is used in the treatment of a variety of clinical conditions, including pneumonia, skin infections, strep throat, staph infections, tonsillitis, bronchitis, otitis media, and gonorrhea. The global cephalosporin market is estimated to reach $1,99,754 million by 2023 from $77,764 million in 2016, growing at a CAGR of 14.4% from 2017 to 2023.

For More Info, Get Sample : http://bit.ly/2A5g37s

The major factors that contribute to the growth of the cephalosporin market include increase in R&D activities to develop highly efficient & safe drugs; upsurge in use of combination therapies; and rise in incidence of pneumonia, tonsillitis, bronchitis, and gonorrhea. Moreover, increased approvals of drugs and growth in awareness about various infections & antibiotic resistance propel the market growth. However, side effects associated with cephalosporin and development of drug-resistant bacterial strains impede the market growth. Conversely, increase in mergers and acquisition among key vendors and development of combination therapies in untapped market are anticipated to provide potential opportunities for the market growth.

The global cephalosporin market is segmented on the basis of generation, type, route of drug administration, application, and region. Based on generation, the market is divided into first-generation cephalosporin, second-generation cephalosporin, third-generation cephalosporin, fourth-generation cephalosporin, and fifth-generation cephalosporin. By type, it is bifurcated into branded and generics.

Depending on route of drug administration, it is classified into injection and oral. The applications covered in the study include respiratory tract infection, skin infection, ear infection, urinary tract infection, sexually transmitted infection, and others. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

• The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors.
• This report provides an extensive analysis of the current and emerging market trends and dynamics in the market through 2016–2023 that helps identify the upcoming market opportunities.
• Recent industry trends and developments and the future opportunities are also covered.
• Extensive knowledge about the key market players and their strategies is provided.
• Comprehensive analysis of the various factors that drive and restrain the growth of the market is provided.

Enquire About Report : http://bit.ly/2jUXtek

Key Market Segments

By Generation

• First-generation Cephalosporin
• Second-generation Cephalosporin
• Third-generation Cephalosporin
• Fourth-generation Cephalosporin
• Fifth-generation Cephalosporin

By Type

• Branded
• Generics

By Route of Drug Administration

• Injection
• Oral

Also Request For Discount : http://bit.ly/2mTKQ43

By Application

• Respiratory Tract Infection
• Skin Infection
• Ear Infection
• Urinary Tract Infection
• Sexually Transmitted Infection
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• France
• Germany
• UK
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

Key market players

• The key players operating in this market include
• Allergan Plc
• Bristol-Myers Squibb Company
• Lupin Limited
• Sanofi
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Merck & Co., Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.

Table Of Content

• CHAPTER 1 INTRODUCTION
• CHAPTER 2 EXECUTIVE SUMMARY
• CHAPTER 3 MARKET OVERVIEW
• CHAPTER 4 CEPHALOSPORIN MARKET, BY GENERATION
• CHAPTER 5 CEPHALOSPORIN MARKET, BY TYPE
• CHAPTER 6 CEPHALOSPORIN MARKET, BY ROUTE OF DRUG ADMINISTRATION
• CHAPTER 7 CEPHALOSPORIN MARKET, BY APPLICATION
• CHAPTER 8 CEPHALOSPORIN MARKET, BY REGION

ABOUT US
WE HAVE A LARGE DATABASE OF QUALITY AND PRECISE MARKET RESEARCH REPORTS THAT WILL BE VERY BENEFICIAL FOR YOUR ORGANIZATION. REPORTS THAT WE SELL OUR AUTHENTIC IN NATURE AND FROM REPUTED PUBLISHERS, HENCE IT CAN DEFINITELY HELP YOU WITH YOUR GROWTH OPPORTUNITIES. RESEARCH BEAM WILL ALWAYS MAKE SURE TO BRING MOST ETHICAL AND HIGH-QUALITY REPORTS. WE VALUE YOUR RELATIONSHIP WITH US AND LOOK FORWARD To A LONG TERM RELATION.

CONTACT US
GLOBAL HEADQUARTERS
5933 NE WIN SIVERS DRIVE,
#205, Portland, OR 97220
UNITED STATES
+1 (800) 910-6452
HELP@RESEARCHBEAM.COM

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cephalosporin Market Growing $1,99,754 million by 2023 here

News-ID: 830614 • Views: 349

More Releases from Research Beam Market

Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% F …
Blood plasma is liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains the blood pressure and helps in exchange of important minerals such as sodium and potassium to maintain the pH balance in the body. Plasma derivatives are products that are manufactured from human plasma by plasma fractionation techniques. These derivatives include albumin, factor
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter monitors are devices that allow prolonged monitoring of heart rhythm from a few days to several months, enabling the detection of infrequent arrhythmias in patients. In addition, holter monitors help identify ventricular tachycardia (VT) in patients with recognized risk of sudden cardiac death. Portability of holter monitors significantly propel the market growth as they can be easily worn by the patients to record heart activity for a certain period
Intermittent Catheters Market Reach $2,950.7 Million By 2023
The global intermittent catheters market was valued at $1,655.5 million in 2016, and is expected to reach $2,950.7 million by 2023 with a CAGR of 8.7% during the forecast period. Intermittent catheter is a disposable medical device, which is used to drain the urinary bladder when an individual is unable to do it naturally. Intermittent catheter consists of a drainage bag that assists to capture the urine. These catheters are
Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024
Continuous glucose monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. The embedded sensor measures the glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor for displaying the results. These systems play an integral role in

All 5 Releases


More Releases for CHAPTER

SISA’s Dharshan Shanthamurthy Addresses ISACA Bangalore Chapter
Bengaluru May 1, 2019: SISA Information Security, a global payment security specialist, announced that Mr. Dharshan Shanthamurthy, Founder and CEO, SISA Information Security recently delivered an informative address on payment security to the ISACA Bangalore Chapter on Saturday 27th April 2019. Mr. Shanthamurthy drew from his own first hand observations of the payment industry, garnered over the years. He spoke about emerging trends in the payments industry, including some of
Chapter 4 of 'Meri Pyaari Bindu'
While the first three chapters of Ayushmann Khurrana and Parineeti Chopra starrer 'Meri Pyari Bindu' tickled our funny bones, the fourth chapter has already made its way. Parineeti shared it on her Twitter handle by tweeting, "So easy to scandalise Abhi's MOM!!! Hahhahahaha here is Chapter 4 :) Bindu v/s Ma 😎😎😎 #MeriPyaariBindu." The chapter 4 shows Tom and Jerry equation between Bindu and Abhimanyu's mom. Bindu, who is Abhi's neighbour
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Robert Wolf as the new Chapter President of AFEA’s Orange, CA Chapter. With the addition of Robert Wolf as the new Chapter President, AFEA is expanding
AFEA Welcomes New Chapter President
The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Anthony Cucchi as the new Chapter President of AFEA’s Newton Square, PA Chapter. With the addition of Anthony Cucchi as the new Chapter President, AFEA is expanding its geographical footprint to cover
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Angelica Jones as the new Chapter President of AFEA’s Glendale, California Chapter. With the addition of Angelica Jones as the new Chapter President, AFEA is expanding
CCIM Washington State Chapter Launches New Website
The Washington State Chapter of CCIM (Certified Commercial Investment Member) announces the launch of its newly designed website at www.CCIMWA.com. “As CCIM-WA continues to grow and expand, we are pleased to announce the launch of our new site that has been redesigned to include quality content to inform, educate, and empower our members and enhance their user experience” said Robert Messmer, CCIM-WA Chapter President. “The new website reflects our